Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
about
Cycloart-24-ene-26-ol-3-one, a New Cycloartane Isolated from Leaves of Aglaia exima Triggers Tumour Necrosis Factor-Receptor 1-Mediated Caspase-Dependent Apoptosis in Colon Cancer Cell LineAnalysis of cell cycle-related proteins in gastric intramucosal differentiated-type cancers based on mucin phenotypes: a novel hypothesis of early gastric carcinogenesis based on mucin phenotype.Concomitant depletion of PTEN and p27 and overexpression of cyclin D1 may predict a worse prognosis for patients with post-operative stage II and III colorectal cancer.IgG expression in human colorectal cancer and its relationship to cancer cell behaviors.SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo.Expression of p21WAF1 in Astler-Coller stage B2 colorectal cancer is associated with survival benefit from 5FU-based adjuvant chemotherapy.Cyclin E involved in early stage carcinogenesis of esophageal adenocarcinoma by SNP DNA microarray and immunohistochemical studies.Prognostic Value of Expression of Cyclin E in Gastrointestinal Cancer: A Systematic Review and Meta-Analysis.The preoperative SUVmax for (18)F-FDG uptake predicts survival in patients with colorectal cancer.Molecular prognostic factors in rectal cancer treated by preoperative chemoradiotherapyIncreased cyclin T1 expression as a favorable prognostic factor in treating gastric adenocarcinoma.Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer.Expression of cyclin E in stage III colorectal carcinomaElevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patients.Expression and clinical role of TCTP in epithelial ovarian cancer.
P2860
Q28551305-8F3C9F1E-5CD7-4E98-912C-37DDCE623202Q33595437-800332C0-5F84-4EE4-A5C4-461A53ADEE95Q34141574-22B17CE4-9C38-45BC-98D9-0C54D34FB6E0Q34469524-F6816231-EA10-484A-B762-23158BD8370AQ34550828-27DB8B1B-5B97-428A-961C-FF74D070057FQ34705611-CD0BB676-BB22-46F5-B573-EB6C93E02B59Q35151182-B6C1650F-0F59-47EA-ADC3-81CD2477212AQ35550222-B3F19BE5-E0DE-42C9-9B18-022228E1EE00Q35874307-7DBEC102-61E8-43CD-9A45-FB879B310AA5Q36216989-0C9BC8F7-8A52-4108-91C4-4CDE010DB76FQ36334152-1ED379E4-09B0-4872-BEBD-37A0D3006812Q36385701-C8666E8A-CE39-407F-BB48-C84F88E2871BQ36475933-6D3E7A79-8939-472E-A9B2-B94F2B42B858Q36511748-3F046470-C672-43BD-869A-D20C9CA42024Q38922573-92C5B12E-DA44-4CB0-ADB5-CA7070480F7C
P2860
Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Expression patterns of cyclins ...... clinicopathological features.
@en
Expression patterns of cyclins ...... clinicopathological features.
@nl
type
label
Expression patterns of cyclins ...... clinicopathological features.
@en
Expression patterns of cyclins ...... clinicopathological features.
@nl
prefLabel
Expression patterns of cyclins ...... clinicopathological features.
@en
Expression patterns of cyclins ...... clinicopathological features.
@nl
P1476
Expression patterns of cyclins ...... clinicopathological features.
@en
P2093
P2860
P304
P356
10.1111/J.1742-1241.2006.01105.X
P577
2008-11-01T00:00:00Z